China National Medicines Corporation Ltd. (600511.SS)
CNY 34.43
(1.89%)
CNY 34.43
(1.89%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.73 Billion | 2.39 Billion | 1.95 Billion | 1.3 Billion | 1.77 Billion | 981.65 Million |
| Net Income | 2.14 Billion | 2.12 Billion | 1.92 Billion | 1.5 Billion | 1.88 Billion | 1.59 Billion |
| Depreciation & Amortization | 208.55 Million | 189.57 Million | 178.82 Million | 172.6 Million | 130.27 Million | 86.99 Million |
| Deferred income taxes | -7.19 Million | -10.04 Million | -20.79 Million | -946.47 Thousand | -40.48 Million | -6 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 511.98 Million | 304.71 Million | 34.56 Million | -219.09 Million | -175.12 Million | -612.11 Million |
| Other non-cash items | -219.79 Million | -227.87 Million | -184.43 Million | -161.08 Million | -59.54 Million | -85.87 Million |
| Investing Cash Flow | -137.08 Million | -152.31 Million | -122.99 Million | -56.46 Million | 14.66 Million | -194.58 Million |
| Investments in PPE | -145.12 Million | -129.77 Million | -95.06 Million | -69.05 Million | -85.72 Million | -132.45 Million |
| Acquisitions | 161.05 Thousand | -15.2 Million | -15.82 Million | 1.2 Million | -31.81 Million | -8.8 Million |
| Investment purchases | - | -24 Million | -18 Million | -11.4 Million | -900 Thousand | -60.2 Million |
| Sales/Maturities of investments | 7.87 Million | 13.13 Million | 5.11 Million | 21.47 Million | 132.16 Million | 6.58 Million |
| Other Investing Activities | 1.00 | 3.52 Million | 782.66 Thousand | 1.3 Million | 933.93 Thousand | 283.24 Thousand |
| Financing Cash Flow | -632.17 Million | -639.57 Million | -745.96 Million | -730.61 Million | -1.21 Billion | -1.07 Billion |
| Debt repayment | -46.8 Million | -509.85 Million | -864.55 Million | -1.06 Billion | -1.5 Billion | -2.24 Billion |
| Dividends payments | -590.02 Million | -528.15 Million | -414.97 Million | -481.37 Million | -305.76 Million | -516.06 Million |
| Common Stock Repurchased | - | - | - | - | -3.00 | -1.00 |
| Common Stock Issuance | - | - | - | - | 3.00 | - |
| Other Financing Activities | 4.64 Million | 482.24 Million | 756.36 Million | 943.25 Million | 742.51 Million | 1.68 Billion |
| Accounts receivables | -292.54 Million | 599.77 Million | -714.21 Million | -107.14 Million | -1.63 Billion | -747.51 Million |
| Accounts payables | 1.04 Billion | -77.42 Million | 1.24 Billion | -411.4 Million | 1.51 Billion | 744.02 Million |
| Inventory | -243.6 Million | -207.58 Million | -475.52 Million | 300.4 Million | -12.94 Million | -602.61 Million |
| Other working capital | -1.00 | -10.04 Million | -20.79 Million | -946.47 Thousand | -40.48 Million | -9.49 Million |
| Cash at beginning of period | 8.89 Billion | 7.22 Billion | 6.14 Billion | 5.62 Billion | 5.05 Billion | 5.33 Billion |
| Cash at end of period | 10.92 Billion | 8.83 Billion | 7.22 Billion | 6.14 Billion | 5.62 Billion | 5.05 Billion |
| Capital Expenditure | -145.12 Million | -129.77 Million | -95.06 Million | -69.05 Million | -85.72 Million | -132.45 Million |
| Effect of forex changes on cash | 64.2 Million | 0.03 | -0.62 | -19.49 Thousand | -677.46 Thousand | -267.51 Thousand |
| Net cash flow / Change in cash | 2.02 Billion | 1.6 Billion | 1.08 Billion | 514.57 Million | 573.23 Million | -286.1 Million |
| Free Cash Flow | 2.58 Billion | 2.26 Billion | 1.86 Billion | 1.23 Billion | 1.69 Billion | 849.19 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 480.76 Million | 541.05 Million | 459.45 Million | 683.7 Million | 2.14 Billion | 477.71 Million |
| Depreciation & Amortization | - | 62.67 Million | 62.67 Million | 52.74 Million | 208.55 Million | -95.7 Million |
| Deferred income taxes | - | - | - | - | -7.19 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -3.2 Billion | - | -536.15 Million | 511.98 Million | 2.1 Billion |
| Other non-cash items | -444.61 Million | 178.61 Million | -2.17 Billion | 2.51 Billion | -219.79 Million | -2.31 Billion |
| Investing Cash Flow | -35.55 Million | -106.79 Million | -2.32 Million | -47.16 Million | -137.08 Million | -31.12 Million |
| Investments in PPE | -40.19 Million | -40.74 Million | -19.6 Million | -47.37 Million | -145.12 Million | -31.18 Million |
| Acquisitions | 261.79 Thousand | 2200.00 | 83.44 Thousand | 9042.96 | 161.05 Thousand | 56.65 Thousand |
| Investment purchases | - | - | -1.37 Million | 0.04 | - | - |
| Sales/Maturities of investments | 4.37 Million | 3.18 Million | 18.56 Million | 252.75 Thousand | 7.87 Million | - |
| Other Investing Activities | 261.79 Thousand | -66.05 Million | 17.27 Million | -57.75 Thousand | 1.00 | 0.21 |
| Financing Cash Flow | -324.29 Million | -1.26 Billion | 116.58 Million | 329.69 Million | -632.17 Million | -99.83 Million |
| Debt repayment | -37.32 Million | -69 Million | -90.46 Million | -26.28 Million | -46.8 Million | -50 Million |
| Dividends payments | -23.97 Million | -671.01 Million | -34.07 Million | -590.02 Million | -590.02 Million | -31.48 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -337.63 Million | -1.27 Billion | 269.16 Million | 945.99 Million | 4.64 Million | -18.35 Million |
| Accounts receivables | - | -2.21 Billion | - | -292.54 Million | -292.54 Million | 1.87 Billion |
| Accounts payables | - | - | - | - | 1.04 Billion | 19.14 Thousand |
| Inventory | - | -1 Billion | - | -243.6 Million | -243.6 Million | 228.75 Million |
| Other working capital | - | 4.2 Million | - | - | -1.00 | -19.14 Thousand |
| Cash at beginning of period | 8.47 Billion | 9.29 Billion | 10.79 Billion | 7.84 Billion | 8.89 Billion | 7.75 Billion |
| Cash at end of period | 8.15 Billion | 8.61 Billion | 9.19 Billion | 10.92 Billion | 10.92 Billion | 7.79 Billion |
| Capital Expenditure | -40.19 Million | -40.74 Million | -19.6 Million | -47.37 Million | -145.12 Million | -31.18 Million |
| Effect of forex changes on cash | - | - | - | 74.78 Million | 64.2 Million | 0.02 |
| Net cash flow / Change in cash | -323.71 Million | -678.74 Million | -1.6 Billion | 3.07 Billion | 2.02 Billion | 44.31 Million |
| Free Cash Flow | -4.04 Million | 616.25 Million | -1.73 Billion | 2.67 Billion | 2.58 Billion | 144.09 Million |
6730
IGEN
UMS
9127
GWA
LFST